4 research outputs found

    Data Analysis of three parameter models of deceleration parameter in FRW Universe

    Full text link
    Constraining the dark energy deceleration parameter is one of the fascinating topics in the recent cosmological paradigm. This work aims to reconstruct the dark energy using parametrization of the deceleration parameter in a flat FRW universe filled with radiation, dark energy, and pressure-less dark matter. Thus, we have considered four well-motivated parameterizations of q(z), which can provide the evolution scenario from the deceleration to acceleration phase of the Universe. We have evaluated the expression of the corresponding Hubble parameter of each parametrization by imposing it into the Friedmann equation. We have constrained the model parameter through H(z), Pantheon, and baryons acoustic oscillation (BOA) data. Next, we have estimated the best-fit values of the model parameters by using Monte Carlo Markov Chain (MCMC) technique and implementing H(z)+ BAO+SNe-Ia dataset. Then we analyzed the cosmographic parameter, such as deceleration, jerk, and snap parameters, graphically by employing the best-fit values of the model parameter. Moreover, we have analyzed statefinder and Om diagnostics parameters for each scenario to discriminate various dark energy models. Using the information criteria, the viability of the models have examined. In the end, we have analogized our outcomes with the standard {\Lambda}CDM model to examine the viability of our model

    Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: An updated meta-analysis of randomized controlled trials

    No full text
    Although individual trials with Target Specific Oral Anticoagulants (TSOACs) have shown decreased rates of intracranial hemorrhage (ICH), there is limited data regarding the absolute and relative benefit of TSOACs in prevention of ICH. We performed a meta analysis to evaluate the absolute risk of ICH with TSOACs in patients with atrial fibrillation (AF), using data from the most recent clinical trials
    corecore